Holen Sie sich die Stockscreener-App
1.64
1.20%
-0.02
Handel nachbörslich:
1.64
Schlusskurs vom Vortag:
$1.66
Offen:
$1.66
24-Stunden-Volumen:
2.40M
Relative Volume:
1.99
Marktkapitalisierung:
$162.50M
Einnahmen:
$97.06M
Nettoeinkommen (Verlust:
$-130.39M
KGV:
-1.0581
EPS:
-1.55
Netto-Cashflow:
$-186.54M
1W Leistung:
-12.30%
1M Leistung:
-3.53%
6M Leistung:
-68.52%
1J Leistung:
-76.54%
1-Tages-Spanne:
$1.5509
$1.685
1-Wochen-Bereich:
$1.5509
$2.09
52-Wochen-Spanne:
$1.55
$7.57
Alector Inc Stock (ALEC) Company Profile
Firmenname
Alector Inc
Sektor
Branche
Telefon
415-231-5660
Adresse
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Vergleichen Sie ALEC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
1.64 | 162.50M | 97.06M | -130.39M | -186.54M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
479.79 | 123.21B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
698.74 | 76.39B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
624.67 | 37.96B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.75 | 31.94B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
271.80 | 29.00B | 3.32B | -860.46M | -1.04B | -8.32 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Herabstufung | Mizuho | Outperform → Neutral |
| 2024-12-16 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-11-29 | Bestätigt | H.C. Wainwright | Buy |
| 2024-11-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-12-14 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2023-09-25 | Eingeleitet | Goldman | Sell |
| 2023-09-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-09-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-04-13 | Eingeleitet | Goldman | Sell |
| 2022-03-08 | Herabstufung | Stifel | Buy → Hold |
| 2021-09-27 | Eingeleitet | William Blair | Outperform |
| 2021-01-15 | Fortgesetzt | BofA Securities | Buy |
| 2020-06-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-28 | Eingeleitet | Goldman | Buy |
| 2020-03-06 | Eingeleitet | Citigroup | Buy |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-02-19 | Eingeleitet | Stifel | Buy |
| 2019-11-21 | Eingeleitet | BTIG Research | Buy |
| 2019-03-04 | Eingeleitet | Barclays | Overweight |
| 2019-03-04 | Eingeleitet | BofA/Merrill | Buy |
| 2019-03-04 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-03-04 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Alector Inc Aktie (ALEC) Neueste Nachrichten
Alector (NASDAQ:ALEC) Receives "Buy" Rating from HC Wainwright - MarketBeat
Alector’s Earnings Call: Progress Amid Challenges - TipRanks
Alector Inc (ALEC) Shares Up Despite Recent Market Volatility - The News Heater
Alector, Inc. (NASDAQ:ALEC) Q4 2024 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Alector Inc Q4 2024 sees cautious market reaction By Investing.com - Investing.com South Africa
Alector Inc (ALEC) Q4 2024 Earnings Call Highlights: Strong Cash Position and Promising Clinical Advances - GuruFocus.com
Alector: Q4 Earnings Snapshot - mySA
The Bold Bet on Brain Health: Alector’s Race Against Time in Neurodegenerative Research - Smartphone Magazine
Alector Inc (NASDAQ:ALEC): The Biotech Pioneering New Frontiers in Neurodegenerative Diseases - Jomfruland.net
Alector Inc (ALEC) Q4 2024 Earnings Call Highlights: Strong Cash Position and Promising ... - Yahoo Finance
Alector, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Alector’s 2024 Financial Results and Clinical Advancements - TipRanks
Alector (ALEC) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings call transcript: Alector Inc Q4 2024 sees cautious market reaction - Investing.com
Alector beats Q4 estimates, shares edge higher By Investing.com - Investing.com Canada
Alector beats Q4 estimates, shares edge higher - Investing.com India
Alector, Inc. SEC 10-K Report - TradingView
Alector Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire
Can Alector's $413M Cash Position Fuel Its Alzheimer's Breakthrough? Q4 Results Reveal Strategy - StockTitan
Alector Inc (ALEC) Q4 2024 Earnings Report Preview: What to Expect - Yahoo Finance
Alector to Participate in Upcoming Healthcare Conferences - GlobeNewswire
Can Alector's March Conference Circuit Signal Progress in Neurodegeneration Therapies? - StockTitan
Alector Inc expected to post a loss of 64 cents a shareEarnings Preview - TradingView
Alector (ALEC) Projected to Post Quarterly Earnings on Wednesday - Defense World
Alector, Inc. (NASDAQ:ALEC) Stock Position Lifted by Vontobel Holding Ltd. - Defense World
Alector to Host Fourth Quarter and Full-Year 2024 Earnings Conference Call - GlobeNewswire
When Will Alector Report Q4 Earnings? Key Date for Biotech Investors - StockTitan
February 2025 US Penny Stocks With Promising Prospects - Simply Wall St
Alector (ALEC) to Release Quarterly Earnings on Tuesday - MarketBeat
25,000 Shares in Alector, Inc. (NASDAQ:ALEC) Acquired by Apollon Wealth Management LLC - Defense World
SG Americas Securities LLC Acquires 8,581 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector, Inc. (NASDAQ:ALEC) Receives $3.75 Consensus PT from Analysts - MarketBeat
Alector stock hits 52-week low at $1.59 amid market challenges - Investing.com Nigeria
Alector, Inc. (NASDAQ:ALEC) Receives $3.75 Average Target Price from Brokerages - Defense World
Alector Reports Third Quarter 2023 Financial Results and Provides Business Update - br.ADVFN.com
Alector stock hits 52-week low at $1.59 amid market challenges By Investing.com - Investing.com South Africa
Alector Reports Third Quarter 2024 Financial Results and Provides Business Update - br.ADVFN.com
Alector Inc (NASDAQ: ALEC) Has Succeeded To Excite In 2025, The Stock Is Down -7.41% Year-To-Date - Marketing Sentinel
ALEC Stock Sees Surge of Approximately 12.20% in Last Five Days - Knox Daily
Alector, Inc. (NASDAQ:ALEC) Short Interest Down 8.5% in January - MarketBeat
AbbVie terminates Alector collaboration agreement - MSN
Cantor Fitzgerald Comments on Alector FY2025 Earnings - Defense World
Finanzdaten der Alector Inc-Aktie (ALEC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Alector Inc-Aktie (ALEC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Rosenthal Arnon | Chief Executive Officer |
Dec 02 '24 |
Sale |
2.52 |
52,172 |
131,442 |
2,507,074 |
| Kenkare-Mitra Sara | President and Head of R&D |
Dec 02 '24 |
Sale |
2.52 |
26,500 |
66,764 |
565,215 |
| Romano Gary | Chief Medical Officer |
Dec 02 '24 |
Sale |
2.52 |
14,892 |
37,519 |
349,283 |
0.22%
0.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):